Automated risk assessment for stroke in atrial fibrillatio
- Conditions
- StrokeCirculatory SystemStroke, not specified as haemorrhage or infarction
- Registration Number
- ISRCTN55722437
- Lead Sponsor
- niversity of Oxford (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 49
1. Practices using clinical software compatible with the intervention (i.e. the EMIS-Web system)
2. Within the study region, namely covering the South East of England, Central England and East Midland & South Yorkshire Primary Care Research Networks (PCRNs)
3. Within participant practices, outcome data will be recorded in patients with diagnosed atrial fibrillation, who justify anticoagulation according to the criteria in NICE guidance TA249
For the pilot study the above criteria (as well as the exclusion criteria below) apply, simply confined to the Thames Valley research partnership area.
The practice may not enter the study if ANY of the following apply:
1. Practices using other clinical software systems than EMIS-Web
2. Practices have recently (within the last 2 years) carried out a major audit of OAC prescribing in eligible patients, including the systematic invitation of patients, using bespoke software tool such as GRASP-AF
3. Practices previously involved in a trial concerning anticoagulation in AF
4. For the main phase of the trial, practices participating in the pilot will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients with diagnosed AF and eligible for anticoagulation under recent guidelines (NICE TA249) who are prescribed this therapy six months after the start of the intervention
- Secondary Outcome Measures
Name Time Method